Patents by Inventor Jennifer Alissa Loyer-Drew

Jennifer Alissa Loyer-Drew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9951065
    Abstract: The present disclosure provides indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors of Formula I: or pharmaceutically acceptable salts thereof, in which X, L, n, m, R1, R2a, R2b, Rn, Rm, and Rt are as defined herein, as well as pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using the same to treat conditions mediated by IDO1.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: April 24, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Mark J. Bartlett, Julian Andrew Codelli, Britton Kenneth Corkey, Jennifer Leigh Cosman, Kristyna Elbel, Jennifer Alissa Loyer-Drew, David Sperandio, Joshua Van Veldhuizen, Hai Yang, Suet Chung Yeung
  • Publication number: 20160333009
    Abstract: The present disclosure provides indoleamine 2,3-dioxygenase 1 (IDOL) inhibitors of Formula I: or pharmaceutically acceptable salts thereof, in which X, L, n, m, R1, R2a, R2b, Rn, Rm, and Rt are as defined herein, as well as pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using the same to treat conditions mediated by IDO1.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 17, 2016
    Inventors: Mark J. Bartlett, Julian Andrew Codelli, Britton Kenneth Corkey, Jennifer Leigh Cosman, Kristyna Elbel, Jennifer Alissa Loyer-Drew, David Sperandio, Joshua Van Veldhuizen, Hai Yang, Suet Chung Yeung
  • Patent number: 8394829
    Abstract: Provided are compounds of Formula I: wherein X is: R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: March 12, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: William R. Baker, Shaopei Cai, Joshua Aaron Kaplan, Musong Kim, Jennifer Alissa Loyer-Drew, Stephane Perreault, Gary Phillips, Lafe J. Purvis, II, Marcin Stasiak, Kirk K. Stevens, Josh Van Veldhuizen
  • Publication number: 20130012504
    Abstract: Provided are compounds of Formula I: R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: Gilead Sciences, Inc
    Inventors: William R. Baker, Shaopei Cai, Joshua Aaron Kaplan, Musong Kim, Jennifer Alissa Loyer-Drew, Stephane Perreault, Gary Phillips, Lafe J. Purvis, II, Marcin Stasiak, Kirk L. Stevens, Josh Van Veldhuizen
  • Publication number: 20110275622
    Abstract: Provided are compounds of Formula I: wherein X is: R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.
    Type: Application
    Filed: May 9, 2011
    Publication date: November 10, 2011
    Applicant: Gilead Sciences, Inc.
    Inventors: William R. Baker, Shaopei Cai, Joshua Aaron Kaplan, Musong Kim, Jennifer Alissa Loyer-Drew, Stephane Perreault, Gary Phillips, Lafe J. Purvis, II, Marcin Stasiak, Kirk L. Stevens, Josh Van Veldhuizen